Company intelligence / Profile preview

Diagnosify

Istanbul, Istanbul Province, Turkeydiagnosify.co.uk ↗

Ownership: Private
Development stage: Commercial

Overview

Diagnosify develops and deploys advanced artificial intelligence-driven platforms for early detection and diagnosis of multiple diseases, including diabetes, Parkinson's disease, heart disease, brain tumors, and Alzheimer's. Their models reportedly achieve high accuracy (>94%) in neurological diagnoses. The company emphasizes rapid results and accessibility for both patients and clinicians.

Therapeutic areas: OncologyEndocrinologyCardiovascularNeurology
Modalities: Device (AI-powered diagnostic platform)Non-pharmacological therapy (digital diagnostics)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Diagnosify.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diagnosify.

Explore the full profile